Safety, Tolerability, & Immunogenicity of V114 Compared to Prevnar 13™ in

See also
Status	Clinical Trial	Phase
Completed	`NCT02201030` - Immunogenicity and Safety Study of NBP606 in Healthy Infants	Phase 3
Completed	`NCT02787863` - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology	Phase 4
Completed	`NCT04031846` - Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-025)	Phase 3
Recruiting	`NCT05920499` - The Effect of AUDIT and Feedback on Pneumococcal Vaccination Coverage	N/A
Completed	`NCT01215175` - Safety and Tolerability Study for the Pneumococcal Conjugate Vaccine V114 Versus Prevnar™ (V114-001)	Phase 1
Completed	`NCT02892812` - A Phase I Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine and 14-valent Pneumococcal Conjugate Vaccine in Adults	Phase 1
Completed	`NCT02116998` - Safety, Tolerability, and Efficacy Study of Prophylactic S. Pneumoniae Vaccine Following Challenge With S. Pneumoniae	Phase 2
Completed	`NCT01446926` - Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and Infants	Phase 1
Completed	`NCT01193582` - A Study To Assess The Safety And Effectiveness Of Prevenar In Chinese Children Who Have Not Previously Received A Vaccine Against Pneumococcal Bacteria	Phase 4
Completed	`NCT00744263` - Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults	Phase 4
Completed	`NCT00492557` - Study Evaluating Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine With Influenza Vaccine in Adults	Phase 3
Completed	`NCT00195611` - Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis Media	Phase 4
Completed	`NCT00137605` - Early Versus Delayed Pneumococcal Vaccination in HIV	Phase 1/Phase 2
Completed	`NCT00205803` - Study Evaluating Pneumococcal Vaccine in Healthy Infants	Phase 1/Phase 2
Completed	`NCT02531373` - A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)	Phase 1/Phase 2
Completed	`NCT03615482` - A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)	Phase 3
Completed	`NCT03565900` - A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Allogeneic Hematopoietic Stem Cell Transplant Recipients (V114-022/PNEU-STEM)	Phase 3
Completed	`NCT04989465` - A Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine	Phase 4
Completed	`NCT02547649` - Safety, Tolerability, and Immunogenicity of Two Formulations of V114 in Healthy Adults 50 Years of Age or Older (V114-006)	Phase 2
Completed	`NCT05477693` - Immunogenicity and Safety of 23-valent Pneumococcal Polysaccharide Vaccine	Phase 4

NCT number	NCT02573181
Study type	Interventional
Source	Merck Sharp & Dohme Corp.
Contact
Status	Completed
Phase	Phase 2
Start date	October 30, 2015
Completion date	January 28, 2016

Safety, Tolerability, and Immunogenicity of V114 Compared to Prevnar 13™ in PPSV23-vaccinated Healthy Adults ≥65 Years of Age (V114-007)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms